The effect of patients' preference on outcome in the EVerT cryotherapy versus salicylic acid for the treatment of plantar warts (verruca) trial

Sarah Cockayne, Kate Hicks, Arthur R. Kangombe, Catherine Hewitt, Michael Concannon, Kim Thomas, Farina Hashmi, Caroline McIntosh, Gwen Brierley, David Torgerson, Ian Watt

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Randomised controlled trials are widely accepted as the gold standard method to evaluate medical interventions, but they are still open to bias. One such bias is the effect of patient's preference on outcome measures. The aims of this study were to examine whether patients' treatment preference affected clearance of plantar warts and explore whether there were any associations between patients' treatment preference and baseline variables in the EverT trial.Methods: Two hundred and forty patients were recruited from University podiatry schools, NHS podiatry clinics and primary care. Patients were aged 12 years and over and had at least one plantar wart which was suitable for treatment with salicylic acid and cryotherapy. Patients were asked their treatment preference prior to randomisation. The Kruskal-Wallis test was performed to test the association between preference group and continuous baseline variables. The Fisher's exact test was performed to test the association between preference group and categorical baseline variables. A logistic regression analysis was undertaken with verruca clearance (yes or no) as the dependent variable and treatment, age, type of verruca, previous treatment, treatment preference as independent variables. Two analyses were undertaken, one using the health professional reported outcome and one using the patient's self reported outcomes. Data on whether the patient found it necessary to stop the treatment to which they had been allocated and whether they started another treatment were summarised by treatment group.Results: Pre-randomisation preferences were: 10% for salicylic acid; 42% for cryotherapy and 48% no treatment preference. There was no evidence of an association between treatment preference group and either patient (p=0.95) or healthcare professional (p=0.46) reported verruca clearance rates. There was no evidence of an association between preference group and any of the baseline variables except gender, with more females expressing a preference for salicylic acid (p=0.004). There was no evidence that the number of times salicylic acid was applied was different between the preference groups at one week (p=0.89) or at three weeks (p=0.24). Similarly, for the number of clinic visits for cryotherapy (p=0.71). Conclusions: This secondary analysis showed no evidence to suggest that patients' baseline preferences affected verruca clearance rates or adherence with the treatment.Trial registration: Current Controlled Trials ISRCTN18994246 and National Research Register N0484189151.

Original languageEnglish
Article number28
JournalJournal of Foot and Ankle Research
Volume5
Issue number1
DOIs
Publication statusPublished - 12 Nov 2012

Fingerprint

Warts
Cryotherapy
Salicylic Acid
Patient Preference
Therapeutics
Podiatry
Random Allocation
Ambulatory Care
Primary Health Care

Cite this

Cockayne, Sarah ; Hicks, Kate ; Kangombe, Arthur R. ; Hewitt, Catherine ; Concannon, Michael ; Thomas, Kim ; Hashmi, Farina ; McIntosh, Caroline ; Brierley, Gwen ; Torgerson, David ; Watt, Ian. / The effect of patients' preference on outcome in the EVerT cryotherapy versus salicylic acid for the treatment of plantar warts (verruca) trial. In: Journal of Foot and Ankle Research. 2012 ; Vol. 5, No. 1.
@article{0ee905d6372d4f598aa52bd762cf1d42,
title = "The effect of patients' preference on outcome in the EVerT cryotherapy versus salicylic acid for the treatment of plantar warts (verruca) trial",
abstract = "Background: Randomised controlled trials are widely accepted as the gold standard method to evaluate medical interventions, but they are still open to bias. One such bias is the effect of patient's preference on outcome measures. The aims of this study were to examine whether patients' treatment preference affected clearance of plantar warts and explore whether there were any associations between patients' treatment preference and baseline variables in the EverT trial.Methods: Two hundred and forty patients were recruited from University podiatry schools, NHS podiatry clinics and primary care. Patients were aged 12 years and over and had at least one plantar wart which was suitable for treatment with salicylic acid and cryotherapy. Patients were asked their treatment preference prior to randomisation. The Kruskal-Wallis test was performed to test the association between preference group and continuous baseline variables. The Fisher's exact test was performed to test the association between preference group and categorical baseline variables. A logistic regression analysis was undertaken with verruca clearance (yes or no) as the dependent variable and treatment, age, type of verruca, previous treatment, treatment preference as independent variables. Two analyses were undertaken, one using the health professional reported outcome and one using the patient's self reported outcomes. Data on whether the patient found it necessary to stop the treatment to which they had been allocated and whether they started another treatment were summarised by treatment group.Results: Pre-randomisation preferences were: 10{\%} for salicylic acid; 42{\%} for cryotherapy and 48{\%} no treatment preference. There was no evidence of an association between treatment preference group and either patient (p=0.95) or healthcare professional (p=0.46) reported verruca clearance rates. There was no evidence of an association between preference group and any of the baseline variables except gender, with more females expressing a preference for salicylic acid (p=0.004). There was no evidence that the number of times salicylic acid was applied was different between the preference groups at one week (p=0.89) or at three weeks (p=0.24). Similarly, for the number of clinic visits for cryotherapy (p=0.71). Conclusions: This secondary analysis showed no evidence to suggest that patients' baseline preferences affected verruca clearance rates or adherence with the treatment.Trial registration: Current Controlled Trials ISRCTN18994246 and National Research Register N0484189151.",
keywords = "Patients' preference, Plantar warts, Randomised controlled trial, Verrucae",
author = "Sarah Cockayne and Kate Hicks and Kangombe, {Arthur R.} and Catherine Hewitt and Michael Concannon and Kim Thomas and Farina Hashmi and Caroline McIntosh and Gwen Brierley and David Torgerson and Ian Watt",
year = "2012",
month = "11",
day = "12",
doi = "10.1186/1757-1146-5-28",
language = "English",
volume = "5",
journal = "Journal of Foot and Ankle Research",
issn = "1757-1146",
publisher = "BioMed Central",
number = "1",

}

The effect of patients' preference on outcome in the EVerT cryotherapy versus salicylic acid for the treatment of plantar warts (verruca) trial. / Cockayne, Sarah; Hicks, Kate; Kangombe, Arthur R.; Hewitt, Catherine; Concannon, Michael; Thomas, Kim; Hashmi, Farina; McIntosh, Caroline; Brierley, Gwen; Torgerson, David; Watt, Ian.

In: Journal of Foot and Ankle Research, Vol. 5, No. 1, 28, 12.11.2012.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effect of patients' preference on outcome in the EVerT cryotherapy versus salicylic acid for the treatment of plantar warts (verruca) trial

AU - Cockayne, Sarah

AU - Hicks, Kate

AU - Kangombe, Arthur R.

AU - Hewitt, Catherine

AU - Concannon, Michael

AU - Thomas, Kim

AU - Hashmi, Farina

AU - McIntosh, Caroline

AU - Brierley, Gwen

AU - Torgerson, David

AU - Watt, Ian

PY - 2012/11/12

Y1 - 2012/11/12

N2 - Background: Randomised controlled trials are widely accepted as the gold standard method to evaluate medical interventions, but they are still open to bias. One such bias is the effect of patient's preference on outcome measures. The aims of this study were to examine whether patients' treatment preference affected clearance of plantar warts and explore whether there were any associations between patients' treatment preference and baseline variables in the EverT trial.Methods: Two hundred and forty patients were recruited from University podiatry schools, NHS podiatry clinics and primary care. Patients were aged 12 years and over and had at least one plantar wart which was suitable for treatment with salicylic acid and cryotherapy. Patients were asked their treatment preference prior to randomisation. The Kruskal-Wallis test was performed to test the association between preference group and continuous baseline variables. The Fisher's exact test was performed to test the association between preference group and categorical baseline variables. A logistic regression analysis was undertaken with verruca clearance (yes or no) as the dependent variable and treatment, age, type of verruca, previous treatment, treatment preference as independent variables. Two analyses were undertaken, one using the health professional reported outcome and one using the patient's self reported outcomes. Data on whether the patient found it necessary to stop the treatment to which they had been allocated and whether they started another treatment were summarised by treatment group.Results: Pre-randomisation preferences were: 10% for salicylic acid; 42% for cryotherapy and 48% no treatment preference. There was no evidence of an association between treatment preference group and either patient (p=0.95) or healthcare professional (p=0.46) reported verruca clearance rates. There was no evidence of an association between preference group and any of the baseline variables except gender, with more females expressing a preference for salicylic acid (p=0.004). There was no evidence that the number of times salicylic acid was applied was different between the preference groups at one week (p=0.89) or at three weeks (p=0.24). Similarly, for the number of clinic visits for cryotherapy (p=0.71). Conclusions: This secondary analysis showed no evidence to suggest that patients' baseline preferences affected verruca clearance rates or adherence with the treatment.Trial registration: Current Controlled Trials ISRCTN18994246 and National Research Register N0484189151.

AB - Background: Randomised controlled trials are widely accepted as the gold standard method to evaluate medical interventions, but they are still open to bias. One such bias is the effect of patient's preference on outcome measures. The aims of this study were to examine whether patients' treatment preference affected clearance of plantar warts and explore whether there were any associations between patients' treatment preference and baseline variables in the EverT trial.Methods: Two hundred and forty patients were recruited from University podiatry schools, NHS podiatry clinics and primary care. Patients were aged 12 years and over and had at least one plantar wart which was suitable for treatment with salicylic acid and cryotherapy. Patients were asked their treatment preference prior to randomisation. The Kruskal-Wallis test was performed to test the association between preference group and continuous baseline variables. The Fisher's exact test was performed to test the association between preference group and categorical baseline variables. A logistic regression analysis was undertaken with verruca clearance (yes or no) as the dependent variable and treatment, age, type of verruca, previous treatment, treatment preference as independent variables. Two analyses were undertaken, one using the health professional reported outcome and one using the patient's self reported outcomes. Data on whether the patient found it necessary to stop the treatment to which they had been allocated and whether they started another treatment were summarised by treatment group.Results: Pre-randomisation preferences were: 10% for salicylic acid; 42% for cryotherapy and 48% no treatment preference. There was no evidence of an association between treatment preference group and either patient (p=0.95) or healthcare professional (p=0.46) reported verruca clearance rates. There was no evidence of an association between preference group and any of the baseline variables except gender, with more females expressing a preference for salicylic acid (p=0.004). There was no evidence that the number of times salicylic acid was applied was different between the preference groups at one week (p=0.89) or at three weeks (p=0.24). Similarly, for the number of clinic visits for cryotherapy (p=0.71). Conclusions: This secondary analysis showed no evidence to suggest that patients' baseline preferences affected verruca clearance rates or adherence with the treatment.Trial registration: Current Controlled Trials ISRCTN18994246 and National Research Register N0484189151.

KW - Patients' preference

KW - Plantar warts

KW - Randomised controlled trial

KW - Verrucae

UR - http://www.scopus.com/inward/record.url?scp=84871769317&partnerID=8YFLogxK

U2 - 10.1186/1757-1146-5-28

DO - 10.1186/1757-1146-5-28

M3 - Article

VL - 5

JO - Journal of Foot and Ankle Research

JF - Journal of Foot and Ankle Research

SN - 1757-1146

IS - 1

M1 - 28

ER -